CM082 in Patients With Myopic Choroidal Neovascularization (CNV)
Status:
Suspended
Trial end date:
2021-12-30
Target enrollment:
Participant gender:
Summary
This is a Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and
Preliminary Efficacy of Intermittent Oral Dosing of CM082 tablets in Chinese Patients With
mCNV.